These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2183695)
1. Felodipine as monotherapy in Asian patients with mild to moderate hypertension. Woo BY; Yeoh TK; Tan AT Ann Acad Med Singap; 1990 Jan; 19(1):64-6. PubMed ID: 2183695 [TBL] [Abstract][Full Text] [Related]
2. Comparison of felodipine and hydrochlorothiazide for the treatment of mild to moderate hypertension in black Africans. Leary WP; Maharaj B J Cardiovasc Pharmacol; 1990; 15 Suppl 4():S91-3. PubMed ID: 1693738 [TBL] [Abstract][Full Text] [Related]
3. Felodipine extended release in mild to moderate hypertension. Wester A; Lorimer AR; Westberg B Curr Med Res Opin; 1991; 12(5):275-81. PubMed ID: 2004539 [TBL] [Abstract][Full Text] [Related]
4. A comparison of isradipine and felodipine in Australian patients with hypertension: focus on ankle oedema. The Physician's Study Group. Hammond JJ; Cutler SA Blood Press; 1993 Sep; 2(3):205-11. PubMed ID: 8205314 [TBL] [Abstract][Full Text] [Related]
5. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group. Dahlöf B; Hosie J Blood Press Suppl; 1993; 1():22-9. PubMed ID: 8173687 [TBL] [Abstract][Full Text] [Related]
6. Once daily felodipine monotherapy in mild to moderate hypertension. Kon SP; Tan HW; Chua CT; Ong ML; Kamsiah J; Maheendran KK; Ponniah CA; Tariq AR; Mahendran T Med J Malaysia; 1992 Dec; 47(4):290-6. PubMed ID: 1303482 [TBL] [Abstract][Full Text] [Related]
7. The antihypertensive efficacy and tolerability of a low dose combination of ramipril and felodipine ER in mild to moderate essential hypertension. Bainbridge AD; Macfadyen RJ; Stark S; Lees KR; Reid JL Br J Clin Pharmacol; 1993 Oct; 36(4):323-30. PubMed ID: 12959310 [TBL] [Abstract][Full Text] [Related]
8. Felodipine, a new calcium antagonist, as monotherapy in mild or moderate hypertension. Cooperative study group. Drugs; 1987; 34 Suppl 3():139-48. PubMed ID: 2894973 [TBL] [Abstract][Full Text] [Related]
9. Felodipine extended-release tablets once daily are equivalent to plain tablets twice daily in treating hypertension. Dutch Hospital Multicentre Group. Hart W; Westberg B J Cardiovasc Pharmacol; 1990; 15 Suppl 4():S65-9. PubMed ID: 1693733 [TBL] [Abstract][Full Text] [Related]
10. Improved efficacy with maintained tolerability in the treatment of primary hypertension. Comparison between the felodipine-metoprolol combination tablet and monotherapy with enalapril. Swedish Multicentre Group. Andersson OK J Hum Hypertens; 1999 Jan; 13(1):55-60. PubMed ID: 9928753 [TBL] [Abstract][Full Text] [Related]
11. Ambulatory 24-h blood pressure assessment of the felodipine-metoprolol combination versus amlodipine in mild to moderate hypertension. Lorraine General Physician Investigators Group. Zannad F; Boivin JM J Hypertens; 1999 Jul; 17(7):1023-32. PubMed ID: 10419077 [TBL] [Abstract][Full Text] [Related]
12. A placebo-controlled dose-response study of felodipine extended release in hypertensive patients. Liedholm H; Melander A J Cardiovasc Pharmacol; 1989 Jul; 14(1):109-13. PubMed ID: 2475701 [TBL] [Abstract][Full Text] [Related]
13. A comparison of felodipine and nifedipine as monotherapies for the treatment of mild to moderate hypertension. Abelardo NS; Ramos EF; Mendoza VL; Sulit YQ; Mitchell MJ J Hum Hypertens; 1989 Feb; 3(1):57-9. PubMed ID: 2657058 [TBL] [Abstract][Full Text] [Related]
14. A dose-finding, placebo-controlled study on extended-release felodipine once daily in treatment of hypertension. Cambell LM; Ross JR; Goves JR; Lees CT; McCullagh A; Barnes P; Timerick SJ; Richardson PD J Cardiovasc Pharmacol; 1989 Dec; 14(6):869-73. PubMed ID: 2481775 [TBL] [Abstract][Full Text] [Related]
15. Antihypertensive efficacy and tolerability of a fixed combination of metoprolol and felodipine in comparison with the individual substances in monotherapy. The Swedish/United Kingdom Study Group. Dahlöf B; Hosie J J Cardiovasc Pharmacol; 1990 Dec; 16(6):910-6. PubMed ID: 1704983 [TBL] [Abstract][Full Text] [Related]
16. Cross-over comparison of nifedipine Oros and felodipine extended release with blind 24 h ambulatory blood pressure assessments. Taverner D; Marley J; Tonkin AL Clin Exp Pharmacol Physiol; 1999 Nov; 26(11):909-13. PubMed ID: 10561813 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of felodipine ER and diltiazem SR as monotherapy in primary hypertension: a double-blind randomized study. Thulin T; Almkvist H; Berglund L; Björnsson T; Fagher B; Henningsen N; Honkavaara M; Naukkarinen V; Nordenström P; Sillanpää J Cardiovasc Drugs Ther; 1994 Dec; 8(6):845-9. PubMed ID: 7742263 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of low felodipine dose monotherapy in mild-to-moderate hypertension: a comparison between office and ambulatory blood pressure monitoring. Podjarny E; Korzets Z; Bernheim J J Hum Hypertens; 1996 Sep; 10 Suppl 3():S153-6. PubMed ID: 8872849 [TBL] [Abstract][Full Text] [Related]
19. Felodipine once daily in elderly hypertensives. Binational MC Study Group (United Kingdom and Netherlands). Hosie J; Mulder AW; Westberg B J Hum Hypertens; 1991 Feb; 5(1):49-53. PubMed ID: 2041036 [TBL] [Abstract][Full Text] [Related]
20. The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients. Liu L; Zhang Y; Liu G; Li W; Zhang X; Zanchetti A; J Hypertens; 2005 Dec; 23(12):2157-72. PubMed ID: 16269957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]